GSK pledges $30bn US investment as UK's pharma woes deepen

GSK said in a statement that $1.2bn would be allocated to build a new factory in Pennsylvania to develop medicines for respiratory diseases and cancer. Construction is planned to start next year. The money will also fund new AI and digital technology tools across GSK's five American manufacturing si...

Redirecting to full article...